NO20003285L - Tetrahydrobenzindolderivater - Google Patents
TetrahydrobenzindolderivaterInfo
- Publication number
- NO20003285L NO20003285L NO20003285A NO20003285A NO20003285L NO 20003285 L NO20003285 L NO 20003285L NO 20003285 A NO20003285 A NO 20003285A NO 20003285 A NO20003285 A NO 20003285A NO 20003285 L NO20003285 L NO 20003285L
- Authority
- NO
- Norway
- Prior art keywords
- hydrogen atom
- integer
- group
- specified substituent
- lower alkyl
- Prior art date
Links
- GHDKZRYOSSRTLA-UHFFFAOYSA-N 2,3,3a,4-tetrahydro-1h-benzo[g]indole Chemical compound C1C=C2C=CC=CC2=C2C1CCN2 GHDKZRYOSSRTLA-UHFFFAOYSA-N 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 8
- 125000001424 substituent group Chemical group 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 2
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 abstract 1
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
- 230000005856 abnormality Effects 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 229940076279 serotonin Drugs 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
- C07D209/92—Naphthostyrils
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP35838197A JPH11189585A (ja) | 1997-12-25 | 1997-12-25 | ５−ｈｔ７受容体結合能を有するテトラヒドロベンズインドール誘導体 |
| JP35838097 | 1997-12-25 | ||
| JP8591398 | 1998-03-31 | ||
| JP13687298 | 1998-05-19 | ||
| JP22970998 | 1998-08-14 | ||
| JP31933698 | 1998-11-10 | ||
| PCT/JP1998/005827 WO1999033804A1 (en) | 1997-12-25 | 1998-12-22 | Tetrahydrobenzindole derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20003285D0 NO20003285D0 (no) | 2000-06-22 |
| NO20003285L true NO20003285L (no) | 2000-08-23 |
| NO317293B1 NO317293B1 (no) | 2004-10-04 |
Family
ID=27551662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20003285A NO317293B1 (no) | 1997-12-25 | 2000-06-22 | Tetrahydrobenzindolderivat, farmasoytisk preparat samt mellomproduktforbindelse |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6498251B1 (no) |
| EP (1) | EP1057814B1 (no) |
| JP (1) | JP4459437B2 (no) |
| KR (1) | KR100588249B1 (no) |
| CN (1) | CN1129578C (no) |
| AT (1) | ATE290527T1 (no) |
| CA (1) | CA2316388C (no) |
| DE (1) | DE69829317T2 (no) |
| DK (1) | DK1057814T3 (no) |
| ES (1) | ES2238778T3 (no) |
| NO (1) | NO317293B1 (no) |
| WO (1) | WO1999033804A1 (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6407112B1 (en) * | 1998-04-22 | 2002-06-18 | Meiji Seika Kaisha, Ltd. | Optically active tetrahydrobenzindole derivative |
| UA69420C2 (uk) * | 1998-10-06 | 2004-09-15 | Янссен Фармацевтика Н.В. | ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ |
| GB9828004D0 (en) * | 1998-12-18 | 1999-02-10 | Smithkline Beecham Plc | Use |
| JP2003512372A (ja) * | 1999-10-18 | 2003-04-02 | スミスクライン ビーチャム パブリック リミテッド カンパニー | テトラヒドロベンゾインドロン誘導体、それらの製造および５−ｈｔ７受容体アンタゴニストとしてのそれらの使用 |
| AR035417A1 (es) * | 2001-01-27 | 2004-05-26 | Hoffmann La Roche | Derivados triciclicos de lactama y sultama, procesos para su elaboracion, medicamentos que los contienen, y el uso de dichos compuestos en la preparacion de medicamentos |
| AU2003256793A1 (en) * | 2002-08-20 | 2004-03-11 | Eli Lilly And Company | Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses |
| JP4517381B2 (ja) * | 2003-08-04 | 2010-08-04 | 曽田香料株式会社 | チエノピリジン系化合物の香料における使用、および新規チエノピリジン系化合物 |
| CZ2006769A3 (cs) * | 2004-05-11 | 2007-03-14 | Egis Gyogyszergyár Nyrt. | Pyridinové deriváty alkyloxindolu jako aktivní látka vuci 5-HT7 receptoru |
| AU2006239302B2 (en) * | 2005-04-26 | 2011-07-07 | Hypnion, Inc. | Benzisoxazole piperazine compounds and methods of use thereof |
| MX2009001036A (es) * | 2006-08-04 | 2009-04-23 | Merz Pharma Gmbh & Co Kgaa | Pirazolopirimidinas, proceso para su preparacion y su uso como medicina. |
| EP1956006A1 (en) * | 2007-02-06 | 2008-08-13 | Laboratorios del Dr. Esteve S.A. | Heterocyclyl-substituted-tetrahydro-naphthalen derivatives as 5-HT7 receptor ligands |
| EP1975161A1 (en) * | 2007-03-28 | 2008-10-01 | Laboratorios del Dr. Esteve S.A. | Heterocyclyl-substituted- tetrahydro-napthalen-amine derivatives, their preparation and use as medicaments |
| WO2009120717A2 (en) * | 2008-03-24 | 2009-10-01 | Medivation Technologies, Inc. | Pyrido [3, 4-b] indoles and methods of use |
| CN102711467A (zh) * | 2009-09-23 | 2012-10-03 | 梅迪维新技术公司 | 吡啶并[3,4-b]吲哚类及使用方法 |
| CN108623585B (zh) * | 2018-05-22 | 2021-07-09 | 中国人民解放军第二军医大学 | β-四氢咔啉类抗真菌药物及其制备方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0937715B1 (en) * | 1996-06-28 | 2005-06-01 | Meiji Seika Kaisha Ltd. | Tetrahydrobenzindole compounds |
| US6407112B1 (en) | 1998-04-22 | 2002-06-18 | Meiji Seika Kaisha, Ltd. | Optically active tetrahydrobenzindole derivative |
-
1998
- 1998-12-22 DE DE69829317T patent/DE69829317T2/de not_active Expired - Lifetime
- 1998-12-22 KR KR1020007007122A patent/KR100588249B1/ko not_active Expired - Fee Related
- 1998-12-22 EP EP98961493A patent/EP1057814B1/en not_active Expired - Lifetime
- 1998-12-22 JP JP2000526488A patent/JP4459437B2/ja not_active Expired - Fee Related
- 1998-12-22 CA CA002316388A patent/CA2316388C/en not_active Expired - Fee Related
- 1998-12-22 WO PCT/JP1998/005827 patent/WO1999033804A1/ja not_active Ceased
- 1998-12-22 CN CN98813811A patent/CN1129578C/zh not_active Expired - Fee Related
- 1998-12-22 US US09/582,416 patent/US6498251B1/en not_active Expired - Fee Related
- 1998-12-22 ES ES98961493T patent/ES2238778T3/es not_active Expired - Lifetime
- 1998-12-22 AT AT98961493T patent/ATE290527T1/de not_active IP Right Cessation
- 1998-12-22 DK DK98961493T patent/DK1057814T3/da active
-
2000
- 2000-06-22 NO NO20003285A patent/NO317293B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR100588249B1 (ko) | 2006-06-13 |
| EP1057814A1 (en) | 2000-12-06 |
| ES2238778T3 (es) | 2005-09-01 |
| DE69829317D1 (de) | 2005-04-14 |
| KR20010033609A (ko) | 2001-04-25 |
| DE69829317T2 (de) | 2006-04-06 |
| WO1999033804A1 (en) | 1999-07-08 |
| CN1129578C (zh) | 2003-12-03 |
| NO20003285D0 (no) | 2000-06-22 |
| CA2316388A1 (en) | 1999-07-08 |
| NO317293B1 (no) | 2004-10-04 |
| DK1057814T3 (da) | 2005-07-04 |
| CA2316388C (en) | 2009-09-08 |
| JP4459437B2 (ja) | 2010-04-28 |
| US6498251B1 (en) | 2002-12-24 |
| CN1286683A (zh) | 2001-03-07 |
| EP1057814B1 (en) | 2005-03-09 |
| ATE290527T1 (de) | 2005-03-15 |
| EP1057814A4 (en) | 2001-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1057814T3 (da) | Tetrahydrobenzindolderivater | |
| YU84791A (sh) | Biciklicni 1-aza-cikloalkalni | |
| FR2662162B1 (fr) | Nouveaux derives de l'amino piperidine, de l'amino pyrrolidine et de l'amino perhydroazepine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
| FI950016A0 (fi) | Heterosykliset yhdisteet lääkeaineena | |
| BG105781A (en) | Piperidine, tetrahydropyridine and piperazine derivatives, their preparartion and use | |
| DE3856378D1 (de) | Substituierte Thiazolidindionderivate | |
| EA200800285A1 (ru) | Новые производные 2,4-дианилинопиримидинов, их получение, лекарственные средства, фармацевтические композиции, содержащие указанные производные, и их применение, в частности, в качестве ингибиторов ikk | |
| WO2004089366A8 (en) | Bicyclic compounds as nr2b receptor antagonists | |
| ATE88714T1 (de) | 2'-desoxy-5-fluoruridinderivate. | |
| ATE503746T1 (de) | Neue imidazolidinderivate | |
| EP0604354A3 (en) | Antidepressant and anti-Parkinson's disease compounds. | |
| DE69202120D1 (de) | Harnstoffderivate, ihre Herstellung und ihre Verwendung bei der Therapie. | |
| DE69937045D1 (de) | Cyclische amidderivate | |
| FI892637A0 (fi) | Menetelmä valmistaa farmakologisesti arvokasta kefeemiyhdistettä | |
| AR005120A1 (es) | Derivados 4-(1h-benzimidazol-2-il) [1,4]diazepanos substituidos utiles para el tratamiento de enfermedades alergicas, composicion farmaceutica y usos en la fabricacion de medicamentos. | |
| CA2203850A1 (en) | Novel n-phenyl-n-phenyliminonethylbenzamidines and their analogues as muscarinic receptor agonists | |
| ATE246682T1 (de) | Benzothiazinderivate | |
| EP1020451A4 (en) | NOVEL ANILIDE COMPOUNDS AND MEDICAMENTS CONTAINING THEM | |
| FI890293A0 (fi) | Foerfarande foer framstaellning av tioformamidderivat. | |
| HUT76276A (en) | 3-substituted 1-arylindole compounds, pharmaceutical compositions containing them and their use | |
| DK0390138T3 (da) | Platinkomplekser og antitumormidler med indhold deraf som aktiv bestanddel | |
| ATE122342T1 (de) | N-sulfenylierte und n-acylierte pyrazoline. | |
| DE69222143D1 (de) | Indanderivate | |
| DE69626624D1 (de) | Medikamente gegen trhombocytopenie | |
| NO20001541L (no) | Nye substituerte dimeriske forbindelser, fremgangsmÕte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ERR | Erratum |
Free format text: TETRAHYDROBENZINDOLDERIVAT, FARMASOYTISK PREPARAT SAMT MELLOMPRODUKTFORBINDELSE |
|
| MM1K | Lapsed by not paying the annual fees |